|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5100 CAD | +6.25% |
|
0.00% | +12.09% |
| Jul. 14 | PharmaCorp to Seek Acquisition Opportunities | CI |
| Jul. 14 | PharmaCorp Rx Closes C$11.5 Million Bought-Deal Offering of Share Units | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | 51x | - | 1.88x | 19.08x | 42.3x | 63.01M | ||
| -.--% | -.--% | 17.84x | 1.57x | 0.75x | 11.77x | 12.64x | 15.44B | ||
| 0.97% | 1.21% | 23.37x | 2.59x | 0.93x | 16.39x | 16.65x | 7.07B | ||
| 2.21% | 2.53% | 16.95x | 1.78x | 0.76x | 7.92x | 10.01x | 6.22B | ||
| 3.02% | 3.32% | 14.21x | 2.13x | 0.91x | 6.6x | 8.64x | 4.02B | ||
| 5.32% | 6.04% | 14.4x | 4.41x | 1.23x | 7.5x | 14.1x | 3.26B | ||
| 4.78% | 5.27% | 14.45x | 2.71x | 0.6x | 4.77x | 7.87x | 3.17B | ||
| 4.3% | 4.71% | 14.92x | 6.75x | 0.91x | 6.73x | 9.35x | 3.04B | ||
| 1.91% | 2.32% | 21.5x | 3.76x | 0.62x | 7.97x | 13.05x | 1.55B | ||
| 0.01% | -.--% | -94.33x | 2.97x | 0.47x | 17.41x | 105.75x | 1.55B | ||
| 4.17% | 4.7% | 12.16x | 0.87x | 0.29x | 2.8x | 5.77x | 964M | ||
| 5.78% | 5.59% | 14.44x | 2.39x | 0.85x | 6.9x | 14.84x | 915M | ||
| 1.36% | 1.96% | 26.4x | 7.2x | 0.96x | 13.03x | 20.2x | 792M | ||
| Average | 2.82% | 3.14% | 11.33x | 3.26x | 0.86x | 9.91x | 21.63x | 3.7B | |
| Weighted average by Cap. | 1.91% | 2.15% | 14.09x | 2.60x | 0.81x | 10.27x | 15.22x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















